Illumina Brass Faces Shareholder Suit Over Grail Deal Debacle

By Katryna Perera · March 11, 2024, 10:08 PM EDT

Current and former directors and executives of Illumina, including former U.S. Food and Drug Administration Commissioner Scott Gottlieb, have been hit with a shareholder derivative suit in California federal court over...

To view the full article, register now.